Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about P53PROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Tumor Protein P53 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
No AI portrait yet
| Gene Symbol | P53PROTEIN |
| Protein Type | Transcription Factor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Subcellular Localization | signals The protein functions as a homotetramer, with each monomer containing 3 |
| Amino Acids | 4477 aa |
| GeneCards | P53PROTEIN |
| Human Protein Atlas | P53PROTEIN |
| N-terminal Transactivation Domain (TAD) | Contains two subdomains (TAD1, TAD2) for transcriptional activation |
| Proline-Rich Domain (PRD) | Mediates protein-protein interactions |
| Central DNA-Binding Domain (DBD) | Binds to p53 response elements (p53 RE) as a tetramer |
| Oligomerization Domain (OD) | Forms tetramers essential for DNA binding |
| C-terminal Regulatory Domain (CTD) | Modulates DNA binding and contains nuclear localization signals |
| Cell Cycle Arrest | Activates p21 to halt cell cycle progression |
| [Apoptosis](/entities/apoptosis) | Induces pro-apoptotic genes (BAX, PUMA, NOXA) |
| DNA Repair | Upregulates DNA repair proteins |
| Associated Diseases | aging, Als, Alzheimer, Alzheimer's disease |
| Known Drugs/Compounds | APR-246, chemotherapy, Emodin, MDM2 antagonist Nutlin-3, rapamycin, RAPAMYCIN |
| Interactions | ACAT1, ACETYL-COA, ACOX1, ACSL4, Actin, ACVR2A |
| KG Connections | 2555 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
P53PROTEIN["P53PROTEIN"]
neurodegeneration["neurodegeneration"]
P53PROTEIN -->|"implicated_in"| neurodegeneration
style P53PROTEIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning P53PROTEIN in their description or question text
No additional research found